rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
Over the last decade, pioneering molecular gene therapy for inner-ear disorders have achieved experimental hearing improvements after a single local or systemic injection of adeno-associated, virus-derived vectors (rAAV for recombinant AAV) encoding an extra copy of a normal gene, or ribozymes used...
Main Authors: | Fabian Blanc, Michel Mondain, Alexis-Pierre Bemelmans, Corentin Affortit, Jean-Luc Puel, Jing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/2/589 |
Similar Items
-
Monobac System–A Single Baculovirus for the Production of rAAV
by: Lionel Galibert, et al.
Published: (2021-08-01) -
Alternative Anesthesia of Neonatal Mice for Global rAAV Delivery in the Brain With Non-detectable Behavioral Interference in Adults
by: Wannan Tang, et al.
Published: (2020-07-01) -
Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
by: Fernando Alvarez-Rivera, et al.
Published: (2020-04-01) -
rAAV-based gene therapy for molybdenum cofactor deficiency type B
by: Jakubiczka-Smorag, Joanna
Published: (2015) -
rAAV-mediated overexpression of TGF-β via vector delivery in polymeric micelles stimulates the biological and reparative activities of human articular chondrocytes in vitro and in a human osteochondral defect model
by: Rey-Rico A, et al.
Published: (2017-09-01)